Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA001196 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA001196, RRID:AB_1078147
- Product name
- Anti-AMOTL1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human AMOTL1, Gene description: angiomotin like 1, Alternative Gene Names: JEAP, Validated applications: ICC, IHC, Uniprot ID: Q8IY63, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Proteolytic activation of angiomotin by DDI2 promotes angiogenesis
Tankyrase inhibition interferes with junction remodeling, induces leakiness, and disturbs YAP1/TAZ signaling in the endothelium
AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis
AMOT130 drives BMP-SMAD signaling at the apical membrane in polarized cells
NEDD4L‐mediated Merlin ubiquitination facilitates Hippo pathway activation
Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP 4 as YAP inhibitor
Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth
Angiomotin-like 2 interacts with and negatively regulates AKT
AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin
Wang Y, Zhu Y, Wang Y, Chang Y, Geng F, Ma M, Gu Y, Yu A, Zhu R, Yu P, Sha Z, Qi S, Li J, Zhao W, Pan W, Zhang R, Yu F
The EMBO Journal 2023;42(15)
The EMBO Journal 2023;42(15)
Tankyrase inhibition interferes with junction remodeling, induces leakiness, and disturbs YAP1/TAZ signaling in the endothelium
Ma N, Wibowo Y, Wirtz P, Baltus D, Wieland T, Jansen S
Naunyn-Schmiedeberg's Archives of Pharmacology 2023;397(3):1763-1789
Naunyn-Schmiedeberg's Archives of Pharmacology 2023;397(3):1763-1789
AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis
Zhou Y, Zhang J, Li H, Huang T, Wong C, Wu F, Wu M, Weng N, Liu L, Cheng A, Yu J, Wong N, Lo K, Tang P, Kang W, To K
Oncogene 2020;39(22):4375-4389
Oncogene 2020;39(22):4375-4389
AMOT130 drives BMP-SMAD signaling at the apical membrane in polarized cells
Brunner P, Hastar N, Kaehler C, Burdzinski W, Jatzlau J, Knaus P, Luo K
Molecular Biology of the Cell 2020;31(2):118-130
Molecular Biology of the Cell 2020;31(2):118-130
NEDD4L‐mediated Merlin ubiquitination facilitates Hippo pathway activation
Wei Y, Yee P, Liu Z, Zhang L, Guo H, Zheng H, Anderson B, Gulley M, Li W
EMBO reports 2020;21(12)
EMBO reports 2020;21(12)
Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP 4 as YAP inhibitor
Vargas R, Duong V, Han H, Ta A, Chen Y, Zhao S, Yang B, Seo G, Chuc K, Oh S, El Ali A, Razorenova O, Chen J, Luo R, Li X, Wang W
The EMBO Journal 2019;39(1)
The EMBO Journal 2019;39(1)
Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth
Ragni C, Diguet N, Le Garrec J, Novotova M, Resende T, Pop S, Charon N, Guillemot L, Kitasato L, Badouel C, Dufour A, Olivo-Marin J, Trouvé A, McNeill H, Meilhac S
Nature Communications 2017;8(1)
Nature Communications 2017;8(1)
Angiomotin-like 2 interacts with and negatively regulates AKT
Han H, Yang B, Wang W
Oncogene 2017;36(32):4662-4669
Oncogene 2017;36(32):4662-4669
AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin
Couderc C, Boin A, Fuhrmann L, Vincent-Salomon A, Mandati V, Kieffer Y, Mechta-Grigoriou F, Del Maestro L, Chavrier P, Vallerand D, Brito I, Dubois T, De Koning L, Bouvard D, Louvard D, Gautreau A, Lallemand D
Neoplasia 2016;18(1):10-24
Neoplasia 2016;18(1):10-24
No comments: Submit comment
No validations: Submit validation data